AXSM Total Utang marang Modal Axsome Therapeutics, Inc.
The current market quotes visualized below demonstrate that the total debt-to-equity ratio for Axsome Therapeutics (AXSM) stands at 2.79. The company's stability is supported by the localization of R&D in developed regions, which mitigates external political risks. The business relies on creating unique combinations of CNS drugs, leveraging the market's high pricing power. An innovative approach to brain chemistry enables the development of effective treatments for migraine and depression.
Rincian analitis lan laporan data perusahaan Axsome Corp (AXSM)
- rega lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data kapitalisasi buku:
- data utang lan likuiditas:
Utang marang Ekuitas Axsome Therapeutics|AXSM - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Axsome Therapeutics|AXSM - Gunggung utang perusahaan|Utang marang nilai buku Axsome Therapeutics|AXSM - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Axsome Therapeutics
Analisis komprehensif perusahaan:AXSM Axsome Therapeutics, Inc.
Axsome Therapeutics' development of CNS therapies with long-term demand requires significant investments in R&D and product commercialization. An analysis of the capital structure ratio (total debt to equity) allows for an assessment of the balance between borrowed and equity resources, determining the business's financial stability and bankruptcy risks under high debt loads during recessionary periods.
Pesaing wigati
Utang marang Ekuitas Biogen (BIIB)|Rasio Utang marang Ekuitas Neurocrine|Regencell - Total Utang marang Modal|Utang marang Modal ACADIA Corp ACAD|Rasio Total Utang marang Ekuitas XENE (Xenon Pharmaceuticals)|vikingtherapeutics.com - Total Utang marang Modal|Utang marang Ekuitas Supernus (SUPN)|CPRX: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas DNLI|Harmony Corp (HRMY) - Utang marang Modal|BHVN (Biohaven Ltd.) - Total Utang marang Modal|Total Utang marang Modal amylyx.com (AMLX)|Rasio Total Utang marang Ekuitas Trevi Therapeutics, Inc. TRVI|Rasio Utang marang Ekuitas PRAX (Praxis Precision Medicines Inc)|Utang marang Ekuitas AVXL|CeriBell EEG - Koefisien Total Utang marang Modal|PRTA (Prothena Corporation plc) - Utang marang Ekuitas|ALEC: Utang marang Modal|ANNX (Annexon) - Utang marang Ekuitas|Omeros (OMER) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal NGNE (Neurogene Corp)|Utang marang Modal AC Immune Inc (ACIU)|Voyager Therapeutics (VYGR) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi neumoratx.com NMRA|Rasio Total Utang marang Ekuitas Scilex (SCLX)|Utang Agregat marang Modal Tevogen Bio Holdings Inc. TVGN|Total Utang marang Modal Alpha Cognition Corp (ACOG)|CGTX - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal IKT|SAVA (cassavasciences.com) - Utang marang Modal|ASRT - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Coya|Total Utang marang Modal VTGN|Total Utang marang Modal OVID (ovidrx.com)|Acumen Pharmaceuticals (ABOS) - Utang marang Ekuitas|Utang Agregat marang Ekuitas cervomed.com CRVO|ATHE (Alterity Therapeutics Ltd) - Total Utang marang Modal|Clene Inc. (CLNN) - Utang marang Modal|PEPG: Rasio Total Utang marang Ekuitas|Total Utang marang Modal Jupiter Neurosciences, Inc.|Relmada Therapeutics (RLMD) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal annovisbio.com|GRCE (Grace Therapeutics, Inc.) - Total Utang marang Modal|Koefisien Total Utang marang Modal Firefly Neuroscience, Inc. (AIFF)|Klotho Neurosciences - Total Utang marang Modal|NeuroSense Therapeutics Ltd - Rasio Total Utang marang Ekuitas|Utang marang Ekuitas RVPH (Reviva Pharmaceuticals)|MTVA - Koefisien Total Utang marang Modal|NRXS: Total Utang marang Modal|Total Utang marang Modal Helius Medical Technologies|Rasio Total Utang marang Ekuitas Passage Bio Inc. (PASG)|Rasio Utang marang Ekuitas NEUP|NERV (Minerva Neurosciences) - Utang marang Ekuitas|Koefisien Total Utang marang Modal ATHA (athira.com)|Addex Therapeutics Ltd - Utang marang Ekuitas|Alzamend Neuro Inc. - Rasio Total Utang marang Ekuitas|Cyclerion (CYCN) - Utang marang Ekuitas|PTIX - Rasio Utang marang Ekuitas|Total Utang marang Modal KTTA|Utang marang Modal Cortigent|ATXI (Avenue Therapeutics, Inc.) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal BCLI|Cara Therapeutics, Inc (CARA) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi CHRO (Chromocell)|ELYM: Utang marang Ekuitas|Utang marang Modal Intra-Cellular Therapies Inc. ITCI|Longboard Pharmaceuticals, Inc. - Total Utang marang Modal|Marinus Pharmaceuticals Inc (MRNS) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas NKGen|NRBO (NeuroBo Pharma) - Rasio Utang marang Ekuitas|SAGE: Utang marang Ekuitas|Koefisien Total Utang marang Modal SNPX|Trevena - Utang marang Ekuitas|Utang marang Modal VIGL (vigilneuro.com)|Anew Medical - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Cerevel Corp CERE